Fund Holdings — TCG Crossover Management, LLC

Total Portfolio Value:
$3.02B
Total Bought:
$494.35M
Total Sold:
$332.99M
Net Transaction:
+$161.36M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ABIVAX Société AnonymeADRS(ABVX)7,111,5967,111,5960$603.77M$959.03M31.74%+$355.26M
Cogent Biosciences, Inc.COMM(COGT)6,798,1625,868,162-930,000$97.62M$208.44M6.90%+$110.82M
CG Oncology, Inc.COMM(CGON)3,670,2063,670,2060$147.84M$152.39M5.04%+$4.55M
Tango Therapeutics, Inc.COMM(TNGX)8,536,19612,762,094+4,225,898$71.70M$113.07M3.74%+$41.37M
Centessa Pharmaceuticals PlcADRS3,136,4804,286,480+1,150,000$76.06M$107.20M3.55%+$31.15M
Dyne Therapeutics, Inc.COMM(DYN)4,615,1444,615,1440$58.38M$90.27M2.99%+$31.89M
Rapt Therapeutics IncCOMM1,636,2752,582,408+946,133$42.20M$87.47M2.89%+$45.27M
Tyra Biosciences, Inc.COMM(TYRA)2,898,1032,898,1030$40.54M$76.19M2.52%+$35.65M
Amylyx Pharmaceuticals, Inc.COMM(AMLX)6,243,8126,243,8120$84.85M$75.43M2.50%-$9.43M
Savara Inc.COMM(SVRA)12,362,20512,362,2050$44.13M$74.54M2.47%+$30.41M
Monte Rosa Therapeutics, Inc.COMM(GLUE)04,622,151+4,622,151$0$72.48M2.40%+$72.48M
Ocular Therapeutix, Inc.COMM(OCUL)6,117,2325,740,231-377,001$71.51M$69.69M2.31%-$1.82M
Dianthus Therapeutics, Inc.COMM(DNTH)1,676,6241,676,6240$65.98M$69.09M2.29%+$3.12M
EyePoint, Inc.COMM(EYPT)3,572,3353,572,3350$50.87M$65.27M2.16%+$14.40M
Structure Therapeutics IncADRS1,063,000920,857-142,143$29.76M$64.05M2.12%+$34.28M
Spyre Therapeutics, Inc.COMM(SYRE)1,100,5821,900,582+800,000$18.45M$62.26M2.06%+$43.82M
Fulcrum Therapeutics, Inc.COMM(FULC)5,250,0005,250,0000$48.30M$59.38M1.97%+$11.08M
Liquidia CorporationCOMM(LQDA)1,710,0841,710,0840$38.89M$58.98M1.95%+$20.09M
Biohaven Ltd.COMM(BHVN)04,631,317+4,631,317$0$52.29M1.73%+$52.29M
Immunovant, Inc.COMM(IMVT)01,660,933+1,660,933$0$42.22M1.40%+$42.22M
Kodiak Sciences Inc.COMM(KOD)1,145,5381,445,538+300,000$18.75M$40.42M1.34%+$21.66M
ADC Therapeutics SACOMM(ADCT)1,390,17511,390,175+10,000,000$5.56M$40.21M1.33%+$34.65M
LB Pharmaceuticals IncCOMM(LBRX)1,745,0161,745,015-1$27.55M$38.84M1.29%+$11.29M
Xencor, Inc.COMM(XNCR)2,452,1382,452,1380$28.76M$37.54M1.24%+$8.78M
Revolution Medicines, Inc.COMM(RVMD)436,473436,4730$20.38M$34.77M1.15%+$14.38M
Agios Pharmaceuticals, Inc.COMM(AGIO)1,430,0411,181,841-248,200$57.40M$32.17M1.06%-$25.23M
Arvinas, Inc.COMM(ARVN)1,617,3652,666,216+1,048,851$13.78M$31.62M1.05%+$17.84M
Relay Therapeutics, Inc.COMM(RLAY)1,810,3513,220,186+1,409,835$9.45M$27.24M0.90%+$17.79M
Janux Therapeutics, Inc.COMM(JANX)01,789,617+1,789,617$0$24.70M0.82%+$24.70M
Entrada Therapeutics, Inc.COMM(TRDA)584,9552,088,392+1,503,437$3.39M$21.47M0.71%+$18.08M
MBX Biosciences, Inc.COMM(MBX)650,000650,0000$11.38M$20.50M0.68%+$9.13M
Upstream Bio, Inc.COMM(UPB)2,117,103743,886-1,373,217$39.82M$20.20M0.67%-$19.63M
Silence Therapeutics plcADRS(SLN)3,033,5603,033,5600$15.74M$18.44M0.61%+$2.70M
UroGen Pharma Ltd.COMM(URGN)717,347717,3470$14.31M$16.80M0.56%+$2.49M
Alector IncCOMM010,000,000+10,000,000$0$15.60M0.52%+$15.60M
Monopar Therapeutics Inc.COMM(MNPR)153,000141,915-11,085$12.50M$9.27M0.31%-$3.23M
Avalo Therapeutics, Inc.COMM(AVTX)483,000483,0000$6.14M$8.77M0.29%+$2.63M
Maze Therapeutics, Inc.COMM(MAZE)0173,816+173,816$0$7.20M0.24%+$7.20M
Mirum Pharmaceuticals, Inc.COMM(MIRM)062,049+62,049$0$4.90M0.16%+$4.90M
LeonaBio, Inc.COMM(LONA)0464,398+464,398$0$3.35M0.11%+$3.35M
Korro Bio, Inc.COMM(KRRO)416,301416,3010$19.94M$3.33M0.11%-$16.60M
Ventyx Biosciences IncCOMM316,195316,1950$983.4K$2.86M0.09%+$1.87M
Vistagen Therapeutics, Inc.COMM(VTGN)2,676,5802,676,5800$9.50M$1.77M0.06%-$7.73M
Adverum Biotechnologies IncCOMM1,668,1740-1,668,174$7.56M$0—-$7.56M
Astria Therapeutics IncCOMM2,761,8610-2,761,861$20.11M$0—-$20.11M
Disc Medicine, Inc.COMM(IRON)465,2570-465,257$30.74M$0—-$30.74M
PepGen Inc.COMM(PEPG)1,200,0000-1,200,000$5.54M$0—-$5.54M
Tourmaline Bio IncCOMM1,311,7830-1,311,783$62.74M$0—-$62.74M
Page 1 of 1